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The healthy brain is able to maintain a stable balance between bottom-up sensory processing and top-down
cognitive control. The neurotransmitter acetylcholine plays a substantial role in this. Disruption of this balance
could contribute to symptoms occurring in psychosis, including subtle disruption of motor control and aberrant
appropriation of salience to external stimuli; however the pathological mechanisms are poorly understood. On
account of the role beta oscillations play in mediating cognitive control, investigation of beta oscillations is
potentially informative about such mechanisms. Here, we used magnetoencephalography to investigate the
eﬀect of the acetylcholinesterase-inhibitor, galantamine, on beta oscillations within the sensorimotor region
during both a sensorimotor task and a relevance–modulation task in healthy participants, employing a double
blind randomized placebo controlled cross-over design. In the galantamine condition, we found a signiﬁcant
reduction in the post-movement beta rebound in the case of executed movements and also in a planned but not
executed movement. In the latter case, the eﬀect was signiﬁcantly greater following task-relevant compared with
irrelevant stimuli. The results suggest that the action of galantamine reduces the inﬂuence of top-down cognitive
processing relative to bottom-up perceptual processing in a manner resembling changes previously reported in
schizophrenia.

1. Introduction
In schizophrenia (Dima et al., 2009) and ADHD (Liddle et al., 2011),
an emerging theme is the hypothesis that imbalance between internally
generated and externally generated mental processes plays a cardinal
role. It is likely that these disorders diﬀer in their underlying cellular or
molecular processes. However, understanding the mechanism by which
the balance between internally and externally generated processes is
maintained in healthy individuals is potentially of great relevance to
understanding how such imbalances result in functional impairment in
mental disorders, and also for rational approaches to developing improved treatments.
Neural oscillations (rhythmic electrophysiological activity in neural
assemblies) are thought to play a core role in mediating both short and
long range coordination between brain regions. Oscillations exist over a
range of frequencies, typically separated into well-deﬁned frequency
bands (alpha, beta etc.). Converging evidence from recent studies
suggests that activity in the lower frequencies (alpha (8–13 Hz) and
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beta (13–30 Hz) range) is reﬂective of cognitive inﬂuence of e.g. attentional networks on primary cortices (Bastos et al., 2015; Fries,
2015). Conversely higher frequency (gamma band (> 30 Hz)) activity
is thought to mediate stimulus driven processing. Such oscillations are
accessible by non-invasive electrophysiological imaging techniques
such as magnetoencephalography (MEG), oﬀering a means to assess,
non-invasively, the balance of internally and externally focussed processing.
Robust modulation of neural oscillations in sensorimotor cortex by
sensory or motor tasks is well known; speciﬁcally initiation of movement generates a reduction of beta amplitude which is sustained
throughout movement (beta desynchronization) and concomitant increase in gamma amplitude (Salmelin et al., 1995; Jurkiewicz et al.,
2006; for a review see Pfurtscheller and Lopes Da Silva, 1999). Cessation of movement drives an increase (above baseline) of beta amplitude
(termed the post movement beta ‘rebound’ (PMBR)). Our recent work
shows that PMBR following a visually cued ﬁnger movement is reduced
in schizophrenia (Robson et al., 2016) and further that this reduction

Corresponding authors.
E-mail addresses: lauren.gascoyne@nottingham.ac.uk (L.E. Gascoyne), peter.liddle@nottingham.ac.uk (P.F. Liddle).

https://doi.org/10.1016/j.nicl.2018.07.019
Received 17 April 2018; Received in revised form 12 June 2018; Accepted 21 July 2018
Available online 23 July 2018
2213-1582/ © 2018 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/BY-NC-ND/4.0/).

NeuroImage: Clinical 20 (2018) 228–235

L.E. Gascoyne et al.

guiding the movement.
Although it is necessary to be cautious in making predictions based
on observations of diﬀerent types of task in diﬀerent species, the contrast of the observed eﬀects of ACh on attention to stimuli with inconsistent predictive power in rats, with the observed increase in PMBR
when the human participant can have greater conﬁdence that the
movement has achieved its intended eﬀect, suggests that enhancement
of cholinergic transmission might diminish PMBR by virtue of discounting top-down prediction in favour of attention to bottom-up
sensory signals. If this prediction were to be conﬁrmed if it would add
conﬁdence to the proposal that PMBR is an index of top-down control.
In the present study we used MEG, recorded during both a simple
sensorimotor and a cognitive task, to assess the eﬀect of the anti-cholinesterase inhibitor, galantamine, on neural oscillations. By inhibiting
the metabolism of Ach, galantamine is expected to enhance cholinergic
neurotransmission. By virtue of shifting the balance away from internally generated (top-down) processing towards external (stimulus
driven or bottom up) processing, we hypothesised that galantamine
would produce a reduction in the post-event beta rebound.

was greater in patients with greater illness severity, i. e. the greater a
patient's severity of illness, the lower their beta rebound value. Supporting this, we have also shown that beta rebound amplitude correlates negatively with schizotypal personality traits in healthy participants (Hunt et al., personal communication).
Evidence indicates that post-movement beta rebound (PMBR) is
associated with the process of maintaining or adapting the brain's internal model that controls movements based on a prediction of the
consequences of those movements (Cao and Hu, 2016). Variation in the
magnitude of PMBR is greater when the discrepancy between the actual
consequence of an action and the intended consequence is small, and
furthermore this eﬀect is increased if the prior performance history
indicates that errors provide information that is useful for updating the
brain's internal model. Cao and Hu (2016) propose that high beta rebound is associated with the process of actively maintaining the current
forward model that guides movement. Our ﬁnding of reduced PMBR in
schizophrenia supports a hypothesis that there is impairment of the
‘top-down’ process by which anterior brain regions modulate perceptual or motor systems. Our previous work using a task designed to
modulate the relevance (or salience) of a stimulus showed that in
schizophrenia there was a decrease in the amplitude of the beta rebound in response to a task-relevant stimulus (Liddle et al., 2016a,b),
consistent with decreased inﬂuences of cognitive attribution of salience,
which we interpret as reﬂective of top-down processing. We bear in
mind that alternative hypotheses regarding the speciﬁc role of beta and
gamma oscillations propose that gamma band oscillations are reﬂective
of higher order cognition, and beta band oscillations index sensorimotor processing (Gaetz & Cheyne 2006, Jensen et al., 2005).
While investigation of biochemical abnormalities in schizophrenia
has been strongly focussed on the neurotransmitters, dopamine and
glutamate, abnormalities of other neurotransmitters, including acetylcholine (Ach), are a topic of continuing research (Higley and
Picciotto, 2014). In relation to the balance between top-down and
bottom-up signalling, Ach is of particular interest. Cholinergic transmission promotes the cortical processing of sensory input, while decreasing the inﬂuence of internally generated signals by suppressing
excitatory top-down connections (Hasselmo and Giocomo, 2006).
However increased cholinergic activity does not merely promote
bottom-up signalling from sensory areas at the expense of all top-down
signalling from anterior brain regions. The complex role of the cholinergic system in attention has been reviewed by Sarter et al. (2005).
Inputs from prefrontal cortex to cholinergic neurons in basal forebrain
nuclei such as the nucleus basalis, modulate the extensive projections of
those cholinergic neurons to other brain regions in a manner that enhances processing of attention-demanding signals while ﬁltering out
irrelevant information. In other circumstances, increased cholinergic
drive from the basal forebrain nuclei can impair performance. Turchi
and Sarter (2001) reported that in rats, increase of ACh input to cerebral cortex, stimulated by infusion of the glutamatergic agonist, NMDA,
in the nucleus basalis, led to increased errors of commission in a sustained visual attention task, apparently reﬂecting impaired top-down
cognitive control.
In rats, ACh plays a role in mediating increased attention to a sensory stimulus in circumstances where the stimulus does not reliably
predict subsequent task-relevant events, compared to circumstances
where the stimulus is predictive of subsequent events (Bucci et al.,
1998). This is consistent with the interpretation that ACh shifts attention towards bottom-up sensory signals and away from top-down predictive signals. This eﬀect of ACH signalling contrasts with the phenomenon of PMBR in humans in situations where the predictability of
the outcome of a joy-stick movement is manipulated by the experimenter unbeknownst to the participant making the movement (Tan
et al., 2016). In such situations, the magnitude of the PMBR is greater
when the participant can be more conﬁdent that the movement has
achieved its intended eﬀect. This suggests that the magnitude of PMBR
is an indicator of greater conﬁdence in the top-down forward model

2. Methods
2.1. Design and participants
Forty-two individuals took part in the study. Two tasks were employed. The ﬁrst was a simple visually cued movement similar to that
used in previous schizophrenia research (Robson et al., 2016; termed
the visuo-motor task). The second was a cognitive task, a relevance
modulation task in which motor response had to be suppressed in the
majority of relevant trials (Liddle et al., 2016a,b). Following removal of
subjects, due to either failure to complete the full set of data acquisitions, or poor data quality, 32 participants (mean age 23.5 (SD 2.7), 14
Female) were included in the visuo-motor task and 36 participants
(mean age 23.6 (SD 2.5), 14 Female) were included in the relevance
modulation task.
The study took place over two scanning days scheduled one week
apart, comprising a double blind within-subjects randomized control
trial with administration of 8 mg of galantamine on one day and a
placebo on the other day. Stratiﬁed randomisation by age and sex was
used to assign participants to “galantamine ﬁrst” or “placebo ﬁrst”
groups. Both pills looked identical. Pills were administered 1.5 h before
MEG scanning took place. Participants were asked to fast for 2 h and
avoid caﬀeine for 12 h prior to taking the pill at both sessions.
Participants were fully informed of the potential for the drug to cause
side eﬀects such as nausea and dizziness, and throughout the study visit
the researcher asked the participants about any symptoms they were
feeling and how severe they were. All participants gave written informed consent to take part in accordance with the Declaration of
Helsinki. The study was approved by the University of Nottingham
Medical School Research Ethics Committee.
2.2. MEG tasks and data acquisition
2.2.1. Visuo-motor task
A red dot on a grey background was presented in the upper right
screen quadrant, and the participants were asked to ﬁxate on this
throughout the experiment. Each trial comprised presentation of a
static, vertical square wave grating (15 degree visual angle, 3 cycles per
degree) in the centre of the screen, appearing in the lower left peripheral vision of the participant for 1.5–2 s. This visual presentation was
followed by 8–8.5 s of ﬁxation with no grating. The time intervals were
jittered randomly. Participants were instructed to make a single right
index ﬁnger abduction as soon as the grating disappeared.
Electromyography (EMG) was recorded using electrodes placed on the
ﬁrst dorsal interosseous muscle of the right hand. 70 trials in total were
recorded for each participant.
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position were excluded.
For the visuomotor task, data were epoched to include the last 1.5 s
of visual grating, and 7 s of rest, in order to account for jitter in the
original trials. Processed trials were therefore 8.5 s long, comprising
0–1.5 s of visual grating stimulation and 1.5–8.5 s of no stimulation.
Only trials containing EMG abductions that were 3 standard deviations
larger than the mean amplitude of the EMG signal, and that occurred
within a time window of 1.6 < t < 2.5 s were included (i. e. within 1 s
of the visual grating oﬀset allowing 1 ms for initiation of movement).
Overall, these preprocessing steps resulted in a mean trial number per
participant of 61 for both drug (SD 8) and placebo (SD 6); these trials
were taken forward for further analysis. There was no signiﬁcant difference in the number of drug and placebo trials as measured using a
related-samples Wilcoxon signed rank test (Z = −0.383, p = .702).
For the relevance modulation task, relevant and irrelevant trials
were epoched into 2 s windows from the onset of the stimulus. Trials
containing button presses were excluded from the analysis. Inspection
of the input signal from the button box showed that button presses
occurred only in relevant trials, but may have occurred erroneously (i.e.
a response may have been made to a non-target trial). To make the
number of relevant and irrelevant trials equivalent within each dataset,
the irrelevant trial following each button press was also removed. These
preprocessing steps resulted in a mean trial number (out of a potential
160 trials) per participant of 147 (SD 18) for drug and 138 (SD 30) for
placebo for both relevant and irrelevant conditions. A related-samples
Wilcoxon signed rank test showed that the diﬀerence in the number of
trials between drug and placebo conditions was not signiﬁcant
(Z = −1.074, p = .283).

2.2.2. Relevance modulation task
The relevance modulation (RM) task involves manipulation of stimulus relevance to elicit neural responses linked to behavioural salience. The paradigm consisted of eight blocks of trials. In each block,
there were two types of stimuli: images of butterﬂies and images of
ladybirds (ladybugs), and two types of block: butterﬂies-relevant and
ladybirds-relevant (see Liddle et al. (2016a,b) for example images).
Blocks lasted for 90 s, including instructions, and consisted of 40 stimuli
(20 butterﬂy images, 20 ladybird images). These blocks were followed
by a 25 s rest period during which time the participant was required to
look at a ﬁxation cross. Stimulus duration was 800 ms, with a minimum
inter-trial interval of 1300 ms, which had a mean random jitter of
200 ms to avoid entrainment.
Subjects were instructed before each block that either the butterﬂies
or the ladybirds would be the relevant stimuli in that block, and to
ignore the interleaving irrelevant stimuli. The eight blocks were presented alternately in the pattern: B–L–B–L–B–L–B–L (where
B = butterﬂies-relevant and L = ladybirds-relevant). For the butterﬂies-relevant blocks, participants were shown a colour-ﬁlled line
drawing of a target butterﬂy with a speciﬁc shape, inner wing colour,
and outer wing colour at the start of the block and instructed to press a
button every time they saw a butterﬂy that matched the target on all
three attributes, while ignoring the interleaved images of ladybirds. In
the ladybirds-relevant condition, an image was a target if there were
equal numbers of red and yellow ladybirds. The ladybirds were positioned and oriented randomly on each stimulus presentation and the
total number of ladybirds ranged between four and six. Participants
were instructed to press a button for a target ladybird image, while
ignoring the interleaving images of butterﬂies. For both block-types
(butterﬂies-relevant and ladybirds-relevant) the probability of a target
being presented was 0.05, a value set intentionally low so as to ensure
close attention to the stimuli while minimizing target trials. All participants were given a full explanation and demonstration of the task
outside the scanner. During the demonstration participants practiced
watching out for the target stimuli and were asked afterwards to make
sure they were able to identify them, although no button presses were
made during the practice. Note that, for analysis, all trials in which a
response was made were eliminated, leaving only relevant trials in
which a button press was successfully supressed.

2.4. Source analysis
Following pre-processing, data were source reconstructed using
adaptive spatial ﬁltering (beamforming) (Robinson and Vrba, 1999;
Van Veen et al., 1997) with source space locations of interest informed
by a cortical atlas. The cortex was parcellated using the Automated
Anatomical Labelling (AAL) atlas (Tzourio-Mazoyer et al., 2002) from
which subcortical regions of interest (ROIs) had been removed, leaving
78 cortical ROIs (Gong et al., 2009). Individual anatomical MRIs were
ﬁrst segmented to remove the skull and scalp using the brain extraction
tool (BET; Smith, 2002) in the fMRIB software library (FSL; Jenkinson
et al., 2012). Our AAL parcellation (which was initially deﬁned in MNI
space) was then transformed to each participant's individual anatomy
using the fMRIB Linear Image Registration Tool (FLIRT; Jenkinson
et al., 2012). For each of the 78 AAL regions, voxels were deﬁned on a
regular 4 mm grid across the whole cortical volume, and the LCMV
beamformer estimated time course of activity derived for each voxel. A
Gaussian weighting function of ~17 mm was applied to the voxel grid
signals within each region to derive a single regional time course biased
towards the centre of mass (Brookes et al., 2016). For beamforming,
data covariance was calculated using a frequency window extending
from 1 to 150 Hz using a 4th order Butterworth ﬁlter, and a time
window which included the whole experiment (Brookes et al., 2008).
The covariance matrix was regularised using the Tikhonov method with
a regularisation parameter equivalent to 5% of the maximum eigenvalue of the unregularised covariance matrix. The forward calculation
was based upon a dipole approximation (Sarvas, 1987) and a multiple
local spheres head model (Huang et al., 1999). Dipole orientation was
calculated using a non-linear search for optimum signal to noise ratio
(SNR). Where necessary, beamformer time courses were sign ﬂipped to
account for arbitrary polarity of the source orientation calculation.
The beamformer was used initially to derive a spatial map, representing change in oscillatory power induced by movement in the
visuo-motor task, within the beta (13–30 Hz) band. For each region,
beamformer projected data were frequency ﬁltered to the band of interest; a Hilbert transform was used to derive the analytic signal, and
the analytic signal used to compute the amplitude envelope (termed

2.2.3. MEG data acquisition
MEG data were acquired using a 275-channel CTF MEG system
(MISL; Coquitlam, BC, Canada) in synthetic 3rd order gradiometer
conﬁguration; at a sampling rate of 600 Hz. Subjects were positioned
supine. To ascertain the location of the head within the MEG helmet,
three head position indicator (HPI) coils were attached to the subject at
the nasion and preauricular points. These were energised throughout
the experiment in order to continuously track the subjects' head position. To allow co-registration of brain anatomy to the MEG sensor
geometry, a measurement of the locations of the HPI coils relative to
the scalp surface was created using a 3D digitiser (Polhemus;
Colchester, VT). Anatomical head images were acquired using a 7 T
Philips MRI scanner (T1 weighted; MPRAGE sequence; 1 mm3 resolution). Co-registration of MEG data to anatomical MRI was achieved by
matching the digitised head surface to the equivalent surface extracted
from the MRI.
2.3. Data pre-processing
MEG data were inspected visually and pre-processed by a single
experienced experimenter who was blinded to the drug and placebo
conditions. Data were ﬁltered between 1 and 150 Hz, and synthetic 3rd
order gradiometer noise cancellation applied. Any trials deemed to
contain excessive interference, for example generated by muscles or eye
movement, were removed. For the both tasks, trials/blocks in which the
subject's head moved > 5 mm (Euclidean distance) from its starting
230
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Hilbert envelope) of oscillations (see also O'Neill et al. (2015)). For the
visuo-motor task, an active window was deﬁned as 2–2.5 s (relative to
the trial start) to encompass the beta desynchronization and a control
window of 3–3.5 s deﬁned to encompass the beta rebound. These
windows were chosen as they represent the largest diﬀerence in power
change across the task. We then computed the mean Hilbert envelope in
both windows, and normalised the diﬀerence by the value in the control
window to yield a measure of fractional change in oscillatory amplitude
induced by the movement. This was done for all AAL regions. Maps
were averaged across participants and used to conﬁrm that the largest
beta eﬀects were in the left somatosensory AAL region. The left somatosensory AAL region was used as the predeﬁned ROI for further analysis of the relevance modulation task, allowing for direct comparison
of the movement and non-movement conditions within the same region
in each participant.

interaction eﬀects of relevance (2 factor levels: relevant and irrelevant)
and drug condition (2 factor levels: galantamine and placebo). This was
undertaken separately for the desynchronisation and rebound for the
beta band values. Post-hoc tests of simple and main eﬀects were conducted as necessary.
For both tasks, in order to rule out any confound of drug side eﬀects,
we undertook a supplementary analysis using the drug side-eﬀect data
for all participants, directly comparing those that experienced side effects and those that did not. Results showed no signiﬁcant diﬀerence in
neural activity between those with drug side eﬀects and those without
in both tasks (see Appendix A for method and results).

2.5. Time-frequency analysis

Fig. 1 shows results for our visuo-motor paradigm, for both galantamine and placebo conditions. Fig. 1A shows task-induced relative
change in beta amplitude across all 78 AAL regions. Results show
clearly that, as expected, beta modulation was observed in bilateral
primary sensorimotor regions, with the largest eﬀect in left postcentral
gyrus (left somatosensory AAL region).
Fig. 1B shows the baseline corrected time-frequency spectrograms
from left postcentral gyrus (primary somatosensory cortex), in which
the expected beta band desynchronisation and rebound in response to a
movement are observable. The upper panel shows the case for the galantamine condition whilst the centre panel shows the case for the
placebo. The lower panel shows the placebo case subtracted from the
galantamine case in a diﬀerence spectrogram. These same data are also
visualised in Fig. 1C, in which the line plots show the averaged time
courses in both conditions. Note that in Fig. 1B and C there is a clear
decrease in beta rebound in response to galantamine. The desynchronisation (2–3 s) and rebound (3–4 s) windows were compared to a
baseline value taken from the end of the trial (7–8 s) for the paired
galantamine and placebo conditions. A Wilcoxon signed rank test was
used to check for signiﬁcant diﬀerences between the two group conditions for desynchronisation, rebound and baseline power. Comparing
mean (over time) amplitudes for the rebound across conditions using a
non-parametric Wilcoxon signed rank test, the observed diﬀerence in
mean values was shown to be signiﬁcant (Z = −2.278, p = .02). Relative to baseline, the mean rebound value for the galantamine condition was 75.52 (SD 175.8) nAm oscillatory amplitude and for the placebo condition 133.97 (SD 205.3) nAm. There was no signiﬁcant eﬀect
of galantamine on the amplitude during the desynchronization window
in the beta band (Z = −0.402, p = .69). There was also no signiﬁcant
diﬀerence in the baseline windows (Z = −1.636, p = .10).

3. Results
3.1. Visuo-motor task

To further assess task-related change in neural oscillatory amplitude, time-frequency spectrograms (TFS) were created for the left somatosensory AAL region for both tasks. For each subject, the beamformer projected time course for this region was frequency ﬁltered into
31 overlapping bands in the 1–150 Hz range. For each band the Hilbert
envelope was calculated and averaged across trials. For the visuo-motor
task, a resting baseline signal for each frequency band was estimated as
the mean Hilbert envelope value in the 6.5–8 s window, and subtracted
from the remaining time course. For the relevance modulation task, a
resting baseline signal was calculated as a grand average of the last 20 s
of each block (i. e. during the rest period), resulting in one resting value
per participant for each frequency band; these values were subtracted
from the resulting relevant and irrelevant time courses. Individual
bands were concatenated in frequency to create time frequency spectrograms, which were then averaged across participants for each drug
condition (galantamine, placebo). For further visualisation, we computed time courses of the frequency band of interest (beta: 13–30 Hz)
by averaging across the applicable rows of the TFS with the baseline
values added back in; these time courses were plotted showing mean
and standard error over subjects in the galantamine and placebo conditions.
2.6. Statistical analysis
After visualisation of the time courses, we tested for a statistically
signiﬁcant eﬀect of drug condition on movement-induced response. For
the visuo-motor task, we computed (for each participant) the mean
value of the Hilbert amplitude in a window encompassing the eventrelated beta desynchronization (2–3 s), a window encompassing the
rebound (3–4 s) and a baseline window (7–8 s). The beta desynchronisation and rebound values are henceforth presented relative to resting
baseline. We tested for a diﬀerence in these two sets of values, across
drug conditions (i. e. between galantamine and placebo) using a twosided Wilcoxon signed rank test of the null hypothesis that a change in
the Hilbert envelope originated from a distribution with a median of
zero when measured independently for all subjects. Bonferroni correction was applied to account for comparisons across the two windows
(desynchronisation and rebound), creating a signiﬁcance threshold
criterion of p = .025.
To test for the statistical signiﬁcance of the eﬀect of drug condition
on the planned movement response relating to the diﬀerence between a
relevant and irrelevant stimulus, we computed (for each participant)
the mean value of the Hilbert amplitude in a window encompassing the
stimulus presentation (0–0.8 s) and the post-stimulus window (1–2 s)
relative to baseline in both the relevant and irrelevant trials, and in the
galantamine and placebo conditions separately. The baseline value was
calculated as the grand average value across all 8 blocks of 25 s baseline
window. We then used a repeated measures ANOVA to investigate any

3.2. Relevance modulation task
Fig. 2 shows time frequency spectra and time courses for beta band
modulation during the relevance modulation task, in the galantamine
and placebo conditions. The left somatosensory AAL region was used as
the region of interest to allow direct comparison with the visuo-motor
task.
Once again a diﬀerence in beta modulation is generated by galantamine, in which the magnitude of the beta rebound is clearly reduced compared to placebo, in the relevant case. This was tested statistically using values relative to resting baseline: For the beta rebound
component, there was a signiﬁcant interaction between the drug factor
and the relevance factor, F(1,35) = 6.3, p = .017. Pair-wise comparisons showed that there was a signiﬁcant eﬀect of drug on the beta
rebound, with galantamine showing a mean diﬀerence of −69.43 (SEM
20.44) nAm compared to the placebo (p = .002) and also a signiﬁcant
eﬀect of relevance on the beta rebound, with the relevant condition
showing a mean diﬀerence of 31.49 nAm (SEM 7.48) compared to the
irrelevant condition (p = .0002). Conversely, for the beta
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Fig. 1. Visuomotor task results: A) Beamformer source reconstructions, at 78 AAL regions, of cortical beta (13–30 Hz) amplitude changes for the motor task. All
images contrast an active window during movement (2–3 s) and a comparison window during the rebound (3–4 s). B) Time frequency spectrograms (baseline
corrected) for left sensory AAL region in the galantamine (top) and placebo (middle) conditions. The lower panel shows the diﬀerence between these for visualisation. C) Hilbert envelope time courses in the beta band, baseline uncorrected. The red time course shows the galantamine condition, the blue time course shows the
placebo condition. Note that in both B and C a marked reduction in the amplitude of the beta rebound with galantamine is observed.

as promoting re-establishment of the status quo in the motor cortex
after the execution of a movement (Engel and Fries, 2010) but more
recently it has been proposed to be an index of long-range integrative
processes, such as the maintenance of the forward model that guides
movement (Cao and Hu, 2016). The observation that a beta signal
apparently arising from dorsolateral prefrontal cortex is time locked to
the occurrence of errors in a cognitive control task such as the Ericson
Flanker task, and predicts the degree of post-error slowing (MarcoPallarés et al., 2008), suggests that top-down beta signals serve a general role in mediating adaptive responses subsequent to perceptuomotor events.
Furthermore, the ﬁndings of Tan et al. (2016) indicating that PMBR
is greater when the participant has greater conﬁdence that the movement has achieved its intended target, suggest the beta rebound reﬂects
an assessment of the match between intention and achieved action. This
observation raises the possibility that the reduction in beta rebound in
the galantamine condition might reﬂect reduced conﬁdence in the reliability of the prediction regarding movement outcome, such as would
be anticipated if galantamine shifts the balance away from processing
internal mental processes towards the processing of external stimuli.
This interpretation is consistent with the proposal that acetylcholine
enhances perceptual learning in circumstances in which consequences
are uncertain by suppressing the use of outdated top-down cues and
boosting bottom-up sensory processing (Yu and Dayan, 2005; Marshall

desynchronisation, there was no signiﬁcant interaction between the
drug factor and relevance factor, F(1,35) = 0.689, p = .41. There were
main eﬀects for drug (F(1,35) = 9, p = .005) and for relevance (F
(1,35) = 22.6, p = .00003). A Wilcoxon signed rank test showed that
there was no signiﬁcant diﬀerence in the baseline values between galantamine and placebo conditions (Z = −1.23, p = .22). In summary,
these results indicate that there is a signiﬁcant diﬀerence in the beta
rebound amplitude for the placebo condition in the relevant trials, indicating that that, in agreement with our visuo-motor data, galantamine reduces the beta rebound amplitude.
4. Discussion
This study investigated the eﬀect of the cholinergic agent galantamine on neural oscillations in healthy participants. In accord with our
hypothesis we found decreased beta rebound following movement in
the visuo-motor task. Similarly, in the relevance modulation task, the
enhancement of PMBR during relevant trials compared with irrelevant
trials observed in the placebo condition, was reduced in the galantamine condition despite the absence of an overt motor response.
4.1. Is PMBR an index of post-event evaluation of action?
It has been proposed that beta rebound reﬂects local processes such
232

NeuroImage: Clinical 20 (2018) 228–235

L.E. Gascoyne et al.

Fig. 2. Relevance Modulation Task Results A) Time frequency spectrograms for averaged relevant, irrelevant and diﬀerence spectrograms in the galantamine and
placebo conditions for the beta band. B) Amplitude envelope time courses (without baseline subtraction) for the beta band. The red time course shows the relevant
condition, the blue time course shows the irrelevant condition.

the expense of top-down processing. The enhancement of attention to
an external stimulus by Ach is especially marked when the stimulus is
relevant or salient (Picciotto et al., 2012).

et al., 2016). We note the alternative hypotheses that Ach might
modulate beta oscillations via cholinergic projections from subcortical
regions (Kondabolu et al., 2016) or from basal forebrain nuclei but
evidence regarding the pathways by which Ach exerts its inﬂuence on
cerebral function is currently inconclusive (see Hasselmo and Sarter,
2011).

4.3. Parallels with schizophrenia
In both of the tasks employed in this study, the decrease in beta
rebound in the galantamine condition relative to the placebo condition,
was similar to the decrease in beta rebound observed in schizophrenia
relative to controls, in our previous studies. Robson et al. (2016) reported diminished beta rebound following an executed motor act in the
visuo-motor task in schizophrenia, while Liddle et al. (2016a,b) reported decreased beta rebound in relevant trials in the Relevance
Modulation task in schizophrenia relative to that in controls. Although
the similarity of the eﬀect of galantamine with the eﬀect observed in
schizophrenia, is consistent with the proposal that in both situations
there is a relative impairment of the top-down control of motor function, the similarity is puzzling in light of the fact that galantamine has
cognitive enhancing properties in early Alzheimer's disease (DarrehShori et al., 2008; Sahoo et al., 2018).
However, given the role of acetylcholine in signalling anticipated

4.2. Beta rebound in the absence of overt motor response
In the relevance modulation task, our observation that beta rebound
was signiﬁcantly greater during relevant trials than irrelevant trials,
despite the absence of an overt motor response in the placebo condition, conﬁrms our earlier observation of a similar eﬀect in healthy
controls in the study by Liddle et al. (2016a,b) that employed the same
task. This observation of greater beta rebound during task-relevant
trials in which relevance is signalled by top-down processing, adds
strength to the interpretation that beta rebound reﬂects top-down
evaluative processing. Furthermore, the observation that galantamine
reduced the magnitude of increase in beta rebound in relevant trials
compared with irrelevant trials in this task provides further support for
the interpretation that galantamine promotes bottom up processing at
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unreliability of predictive cues (Yu and Dayan, 2005) our ﬁndings are
consistent with the proposal by Hemsley (1987) that a basic disturbance
in schizophrenia is weakening of the inﬂuence of stored memories of
regularities of previous input on current perception. More recently,
Silverstein and Keane (2009) demonstrated that when top-down feedback is required to organize novel or weakly grouped stimuli, learning
of perceptual organization tends not to occur in schizophrenia. Thus the
observation of similarities between the eﬀect of galantamine and the
eﬀect of suﬀering from schizophrenia on beta rebound might reﬂect
similar weakening of the top- down inﬂuence. PMBR might indeed be
useful index of impaired top-down processing in schizophrenia that can
be elicited using a simple perceptual-motor task.

5. Conclusion
In conclusion, our ﬁndings are consistent with the hypothesis that
galantamine diminishes the eﬀect of top-down inﬂuences on post-event
adaptive processes in motor cortex, perhaps due to an increased attentional focus on the processing of external stimuli. The similarity of
the eﬀects of galantamine on beta rebound, with the diminution of beta
rebound observed in schizophrenia suggests that further understanding
of the mechanism of the eﬀects of galantamine might enhance understanding of the pathophysiology of schizophrenia, and also of cognitive
control deﬁcits in ADHD.
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The observed eﬀects of galantamine contrast with those of the
cholinesterase inhibitor physostigmine. Physostigmine produces a
marked increase in the alpha/beta desynchronization during the performance of attention-demanding tasks in parietal and occipital regions, but shows less prominent eﬀects on post-event beta synchronisation (Bauer et al., 2012). In contrast, our results show no eﬀect on
beta desynchronization during perceptual processing but an appreciably diminished post-event beta rebound. It should be noted that although both galantamine and physostigmine are cholinesterase inhibitors, galantamine also increases the responsiveness of cholinergic
nicotinic receptors to ACh. By virtue of inhibiting the metabolism of
ACh, both drugs would be expected to achieve pro-cholinergic eﬀects
via both muscarinic and nicotinic receptors, but the nicotinic eﬀects
might be expected to dominate with galantamine.
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Appendix A. Investigating the inﬂuence of drug side eﬀects
Table A1 shows the side eﬀects experienced by the full study cohort, with some participants experiencing more than one side eﬀect. In order to
investigate the inﬂuence of drug side eﬀects on results, we split the participant groups depending on whether they reported any drug side eﬀects, or
reported feeling ‘ﬁne’ after taking the drug. There were some eﬀects present in the placebo condition, however these were few and mild, and could be
accounted for by caﬀeine withdrawal for example, so did not warrant explicit investigation. Participant numbers for each task are reported in Table
A2.
Table A1
Symptom

Drug day (N)

Placebo day (N)

No symptoms
Nausea
Drowsy
Dizzy
Stomach pain
Lightheaded
Headache
Blurry vision
Heartburn
Overheating
Elevated heart rate
Adverse eﬀects (vomiting, severe dizziness)

23
9
3
9
2
2
1
–
–
1
1
3

36
–
3
–
–
2
1
1
1
–
–
–

Table A2
Task

Felt ‘ﬁne’ (N)

Drug side eﬀects (N)

Visuo-motor
Relevance Modulation

17
21

15
15
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Visuo-motor task
Using a series of 2-tailed Mann-Whitney U tests, we investigated the eﬀect of galantamine side eﬀects on the cortical responses. We compared the
desynchronisation, rebound and baseline for beta frequency oscillations between the subset of participants with side eﬀects and those without, only
within the galantamine data (excluding the placebo data). For the beta frequency, there was no signiﬁcant diﬀerence between the groups in the
desynchronisation condition (Z = −1.1114, p = .265), the rebound condition (z = −0.925, p = .355), or the baseline (z = −0.774, p = .439).
Relevance modulation task
We used a mixed design ANOVA to compare the diﬀerences in the repeated measures components of desynchronization and rebound between the
two independent galantamine groups (side eﬀect and no side eﬀect) in both the relevant and irrelevant conditions. There was no signiﬁcant between
subjects eﬀect F(1,34) = 1.3, p = .262, indicating that there was no eﬀect of galantamine side eﬀect on the cortical responses for the relevance
condition. Baseline values were tested separately, using a 2-tailed Mann-Whitney U test. There were no signiﬁcant diﬀerences between the beta
frequency baseline values for the side eﬀect and no side eﬀect groups (z = −1.112, p = .911).
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